Pravachol (pravastatin) is approved to prevent a first heart attack
January 1998
There's more good news about the "statins"...
Last month we told you that Pravachol (pravastatin) is approved to prevent a first heart attack...in patients with high cholesterol.
Now there's evidence that Mevacor (lovastatin) reduces the risk of a first heart attack...even in healthy patients with average cholesterol.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive